How Australia's strategic deployment of antiviral medications has become a secondary defense line against severe COVID-19 outcomes.
Discover how 1,4,4-trisubstituted piperidines offer a novel approach to blocking coronavirus replication through non-covalent inhibition of the main protease.
Discover how cordifolioside from Tinospora cordifolia (giloy) simultaneously inhibits SARS-CoV-2 replication and modulates immune response, offering a dual-action solution against COVID-19.
Exploring how gene therapy using interferon-beta creates long-lasting antiviral states in human cells to combat viral infections.